Clinical Outcomes of Treatment-Naive Transformed vs. De Novo Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis of 1735 Cases.

Cancers (Basel) · 2026 · PMC13205124 · PMID 42192999

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

a nonsignificant trendp = 0.23not close (p > 0.1)

For OS, pure transformation showed only a nonsignificant trend toward worse survival compared with de novo DLBCL ( p = 0.23), and OS did not differ significantly among de novo DLBCL, concurrent trDLBCL, and pure transformation (log-rank p = 0.56; Figure S1 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.